Rv0129c: fbpCRv0340Rv0341: iniBRv0342: iniARv0343: iniCRv1483: mabARv1484: inhARv1854c: ndhRv1592cRv1772Rv1908c: katG1909c: furARv2242: srm R homologRv2243: fabDRv2245: kasARv2247: accD6Rv2427A: oxyRRv2428: ahpCRv2846c: efpARv3139: fadE24Rv3566c: nhoARv3795: embB

Rv2428

More about Rv2428 on    TBDB.org

More about Rv2428 on    TubercuList

Return to gene list

Display all mutations or select a bar from the histogram above to examine in greater detail

Display high confidence mutations only

Rv2428: all mutations (high confidence mutations are highlighted in yellow)
Primary reference Polymorphism Nucleotide position Codon position Amino acid Time period Origin Molecular detection method Gene coverage Resistance pattern MIC Susceptibility testing method R/Total isolates R/S isolates with mutation Additional mutations High confidence support
Rindi L Int J Tuberc Lung Dis 2005 G/A -74 -74 - 1994-2002 Italy Sequencing nt 583-819 36H,9MDR 0.1ug/ml BACTEC 460 45/45 1/0 not mentiond -
Huang WL JCM 2009 G/A -66 -66 - 2007-2008 Taiwan Sequencing N.S. 242MDR N.S. MGIT 960 242/272 2/0 not mentiond -
Rindi L Int J Tuberc Lung Dis 2005 C/T -54 -54 - 1994-2002 Italy Sequencing nt 583-819 36H,9MDR 0.1ug/ml BACTEC 460 45/45 1/0 not mentiond -
Gagneux S PLOS Path 2006 ins ATGT -54 -54 - - - - - - - - - - - -
No Publication Listed C/T -52 -52 - - - - - - - - - - - -
Doustdar F MDR 2008 T/G -49 -49 - 2005-2006 Iran Sequencing 250bp around 315 and 212 bp around 463, 238bp of inhA and 293bp of ahpC H N.S. Proportion method 48/93 1/0 None -
Ramaswamy SV AAC 2003 G/A -48 -48 - - - - - - - - - - - -
Lee ASG AAC 1999 G/A -46 -46 - 1994-1996 Singapore Sequencing oxyRahpC intergenic region H 0.1ug/ml BACTEC 460 160/192 1/0 katG del/mut or inhA mutation
Secondary Publication: Hazbon MH AAC 2006 del G -46 -46 - - - - - - - - - - - -
Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 C/T -45 -45 - - - - - - - - - - - -
Sreevatsan S AAC 1997 (*) T/A -44 -44 - 1997 Brazil, Chile, Mexico, Venezuela, Kenya, Yemen, Philippines, Japan, Netherlands, Romania, USA Sequencing oxyRahpC intergenic region - - Proportion method, BACTEC 460 70/169 1/0 katG deletion -
Silva MS JCM 2003 T/C -40 -40 - 1996-1999 Brazil PCR-SSCP, Sequencing oxyRahpC intergenic region H,HR,HRS,HRP,HS,HRE,HRES,HRESP - Proportion method 69/69 1/0 S315T kat G -
Silva MS JCM 2003 C/T -39 -39 - 1996-1999 Brazil PCR-SSCP, Sequencing oxyRahpC intergenic region H,HR,HRS,HRP,HS,HRE,HRES,HRESP - Proportion method 69/69 2/0 none
Baker LV AAC 2005 T/A -34 -34 - 1998 United Kingdom Directed Oligonucleotide array, Sequencing oxyRahpC intergenic region H,HS,HE,HSE,MDR ratio>=1 Resistance ratio method 202/378 1/0 Arg463Leu katG -
Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 T/C -34 -34 - - - - - - - - - - - -
Baker LV AAC 2005 del T -34 -34 - 1998 United Kingdom Directed Oligonucleotide array, Sequencing oxyR'-ahpC intergenic region H,HS,HE,HSE,MDR ratio>=1 Resistance ratio method 202/378 1/0 S315T, Arg463Leu katG -
Sreevatsan S AAC 1997 (*) G/A -32 -32 - 1997 Brazil, Chile, Mexico, Venezuela, Kenya, Yemen, Philippines, Japan, Netherlands, Romania, USA Sequencing oxyRahpC intergenic region H - BACTEC 460 radiometric method or Proportion method for MTB and Mafricanum isolates only 70/169 1/0 none -
Huang WL JCM 2009 C/T -32 -32 - 2007-2008 Taiwan Sequencing N.S. 242MDR N.S. MGIT 960 242/272 1/0 not mentiond -
Lee ASG AAC 1999 C/T -30 -30 - 1994-1996 Singapore Sequencing oxyRahpC intergenic region H 0.1ug/ml BACTEC 460 160/192 2/0 katG del/mut or inhA mut -
Baker LV AAC 2005 C/T -20 -20 - 1998 United Kingdom Directed Oligonucleotide array, Sequencing oxyRahpC intergenic region H,HS,HE,HSE,MDR ratio>=1 resistance ratio method 202/378 1/0 none -
Gagneux S PLOS Path 2006 C/T -15 -15 - - - - - - - - - - - -
Lee ASG AAC 1999 C/T -12 -12 - 1994-1996 - - - - - - - - - -
Gagneux S PLOS Path 2006 C/A -10 -10 - - - - - - - - - - - -
Gagneux S PLOS Path 2006 C/T -10 -10 - - - - - - - - - - - -
Secondary Publication: Hazbon MH AAC 2006 C/G -10 -10 - - - - - - - - - - - -
Silva MS JCM 2003 G/A -9 -9 - 1996-1999 Brazil PCR-SSCP, Sequencing Promoter region of ahpC H,HR,HRS,HRP,HS,HRE,HRES,HRESP - Proportionmethod on Ogawa medium 69/69 1/0 none -
Lee ASG AAC 1999 G/A -6 -6 - 1994-1996 Singapore Sequencing Promoter region of ahpC H 0.1ug/ml BACTEC 460 160/192 1/0 katG del/mut or inhA mut -
Huang WL JCM 2009 G/A -5 -5 - 2007-2008 Taiwan Sequencing N.S. 242MDR N.S. MGIT 960 242/272 1/0 not mentiond -
Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 A/G -4 -4 - - - - - - - - - - - -
Huang WL JCM 2009 ins A -4 -4 - 2007-2008 Taiwan Sequencing N.S. 242MDR N.S. MGIT 960 242/272 1/0 not mentiond -
Secondary Publication: Hazbon MH AAC 2006 ins T -4 -4 - - - - - - - - - - - -
Gagneux S PLOS Path 2006 T/C 0 0 - - - - - - - - - - - -
Lee ASG AAC 1999 CCA/TCA 4 2 Pro/Ser 1994-1996 Singapore Sequencing Promoter region of ahpC H 0.1ug/ml BACTEC 460 160/192 1/0 katG del/mut or inhA mut -
Kiepiela P Tuber Lung Dis 2000 CTG/AAG 7 3 Leu/Lys 1995 South Africa PCR-SSCP, Sequencing N.S H >8ug/ml BACTEC 460 79/96 1/0 Pro2Pro ahpC, katG mut present but not specified -
Lee ASG AAC 1999 ACC/ATC 14 5 Thr/Ile 1994-1996 Singapore Sequencing Promoter region of ahpC H 0.1ug/ml BACTEC 460 160/192 1/0 katG del/mut or inhA mut -
Silva MS JCM 2003 TTC/ATC 28 10 Phe/Ile 1996-1999 Brazil PCR-SSCP, Sequencing Promoter region of ahpC H,HR,HRS,HRP,HS,HRE,HRES,HRESP - Proportionmethod on Ogawa medium 69/69 1/0 S315T katG -
Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 GAC/AAC 97 33 Asp/Asn - - - - - - - - - - -
Secondary Publication: Hazbon MH AAC 2006 GAC/CAC 217 73 Asp/His - - - - - - - - - - -
Chan RCY JAC 2007 GAG/AAG 226 76 Glu/Lys 1994-2004 Hong Kong PCR-SSCP, Sequencing Whole gene N.S. - Absolute concentration method 250 241 2 -
Secondary Publication: Hazbon MH AAC 2006 CTC/CGC 572 191 Leu/Arg - - - - - - - - - - -

Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations.


© 2010 Andreas Sandgren  |  Supported by the Swedish Research Council  |  Contact Database Curator